The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.The HIPAA authorization form alone adds an average of two pages of additional material to the ICF. ... Several organizations have tried to remedy the ICF comprehension problem by creating guidelines and templates that call for ICFs to beanbsp;...
|Title||:||A National Cancer Clinical Trials System for the 21st Century:|
|Author||:||Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services, Institute of Medicine|
|Publisher||:||National Academies Press - 2010-07-08|